Those at Highest Risk for Severe COVID-19 Often Least Likely to Get Monoclonal Antibodies
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and…